Simplex Trading, LLC Logic Bio Therapeutics, Inc. Transaction History

Simplex Trading, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	BUY	$0.29 - $0.67 $174 - $402	600 Added 1500.0%	640 $0
Q2 2022 Aug 03, 2022	BUY	$0.35 - $0.74 $14 - $29	40 New	40 $0
Q1 2022 May 02, 2022	SELL	$0.61 - $2.49 $5,908 - $24,118	-9,686 Closed	0 $0
Q4 2021 Feb 23, 2022	BUY	$2.2 - $4.53 $19,503 - $40,158	8,865 Added 1079.78%	9,686 $22,000
Q2 2021 Aug 12, 2021	BUY	$4.03 - $7.57 $3,308 - $6,214	821 New	821 $3,000

Ticker LOGC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,962,700
Description
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.